Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Page 1
Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.
Kleiman NS, Van Mieghem NM, Reardon MJ, Gada H, Mumtaz M, Olsen PS, Heiser J, Merhi W, Chetcuti S, Deeb GM, Chawla A, Kiaii B, Teefy P, Chu MWA, Yakubov SJ, Windecker S, Althouse AD, Baron SJ. Kleiman NS, et al. Among authors: reardon mj. JACC Cardiovasc Interv. 2024 Apr 22;17(8):979-988. doi: 10.1016/j.jcin.2024.02.014. JACC Cardiovasc Interv. 2024. PMID: 38658126 Clinical Trial.
BACKGROUND: Symptomatic patients with severe aortic stenosis (AS) at high risk for surgical aortic valve replacement (SAVR) sustain comparable improvements in health status over 5 years after transcatheter aortic valve replacement (TAVR) or SAVR. Whether a similar long-term …
BACKGROUND: Symptomatic patients with severe aortic stenosis (AS) at high risk for surgical aortic valve replacement (SAVR) sustain comparab …
Transcatheter or Surgical Aortic Valve Replacement in Women with Small Annuli at Low or Intermediate Surgical Risk.
Modine T, Forrest JK, Van Mieghem NM, Deeb GM, Yakubov SJ, Ali WB, Tchétché D, Lam KY, Oh JK, Huang J, Mehran R, Reardon MJ. Modine T, et al. Among authors: reardon mj. Am J Cardiol. 2024 Apr 17:S0002-9149(24)00273-X. doi: 10.1016/j.amjcard.2024.04.013. Online ahead of print. Am J Cardiol. 2024. PMID: 38641189
We evaluated 2-year clinical and hemodynamic outcomes following AVR to understand acute valve performance and early and mid-term clinical outcomes. This post hoc analysis pooled women enrolled in the randomized, prospective, multicenter Evolut Low Risk and SURTAVI intermed …
We evaluated 2-year clinical and hemodynamic outcomes following AVR to understand acute valve performance and early and mid-term clin …
2-Year Clinical and Echocardiography Follow-Up of Transcatheter Mitral Valve Replacement With the Transapical Intrepid System.
Bapat V, Weiss E, Bajwa T, Thourani VH, Yadav P, Thaden JJ, Lim DS, Reardon M, Pinney S, Adams DH, Yakubov SJ, Modine T, Redwood SR, Walton A, Spargias K, Zhang A, Mack M, Leon MB. Bapat V, et al. Among authors: reardon m. JACC Cardiovasc Interv. 2024 Apr 1:S1936-8798(24)00527-2. doi: 10.1016/j.jcin.2024.02.033. Online ahead of print. JACC Cardiovasc Interv. 2024. PMID: 38639690
BACKGROUND: Thirty-day outcomes with the investigational Intrepid transapical (TA) transcatheter mitral valve replacement (TMVR) system have previously demonstrated good technical success, but longer-term outcomes in larger cohorts need to be evaluated. OBJECTIVES: The aut …
BACKGROUND: Thirty-day outcomes with the investigational Intrepid transapical (TA) transcatheter mitral valve replacement (TMVR) system have …
Echocardiographic Profiling Predicts Clinical Outcomes After Mitral Transcatheter Edge-to-Edge Repair.
Hatab T, Samimi S, Bou Chaaya RG, Qamar F, Kharsa C, Wessly P, Faza N, Little SH, Atkins MD, Reardon MJ, Kleiman NS, Zoghbi WA, Nagueh SF, Zaid S, Goel SS. Hatab T, et al. Among authors: reardon mj. J Am Heart Assoc. 2024 Mar 5;13(5):e032784. doi: 10.1161/JAHA.123.032784. Epub 2024 Feb 23. J Am Heart Assoc. 2024. PMID: 38390821 Free PMC article.
We sought to examine the prognostic value of combining predischarge MR, TR, and TMPG to study long-term outcomes after TEER. METHODS AND RESULTS: We reviewed the records of 291 patients who underwent successful mitral TEER at our institution between March 2014 and June 202 …
We sought to examine the prognostic value of combining predischarge MR, TR, and TMPG to study long-term outcomes after TEER. METHODS …
Five-Year Follow-Up from the CoreValve Expanded Use Transcatheter Aortic Valve-in-Surgical Aortic Valve Study.
Bajwa TK, Laham RJ, Khabbaz K, Dauerman HL, Waksman R, Weiss E, Allaqaband S, Badr S, Caskey M, Byrne T, Applegate RJ, Kon ND, Li S, Kleiman NS, Reardon MJ, Chetcuti SJ, Deeb GM. Bajwa TK, et al. Among authors: reardon mj. Am J Cardiol. 2024 Mar 1;214:1-7. doi: 10.1016/j.amjcard.2023.11.071. Epub 2023 Dec 17. Am J Cardiol. 2024. PMID: 38110018
Transcatheter aortic valve replacement (TAVR) provides an option for extreme-risk patients who underwent reoperation for a failed surgical aortic bioprosthesis. Long-term data on patients who underwent TAVR within a failed surgical aortic valve (TAV-in-SAV) are limited. .. …
Transcatheter aortic valve replacement (TAVR) provides an option for extreme-risk patients who underwent reoperation for a failed surgical a …
Surgical Explantation of Failed Transcatheter Aortic Valve Replacement.
Zaid S, Hirji SA, Bapat VN, Denti P, Modine T, Nguyen TC, Mack MJ, Reardon MJ, Kaneko T, Tang GHL; EXPLANT-TAVR Investigators. Zaid S, et al. Among authors: reardon mj. Ann Thorac Surg. 2023 Nov;116(5):933-942. doi: 10.1016/j.athoracsur.2023.05.036. Epub 2023 Jun 22. Ann Thorac Surg. 2023. PMID: 37354965
BACKGROUND: Recent reports have demonstrated worse than expected outcomes of surgical explantation after transcatheter aortic valve replacement (TAVR). However in-depth analysis of the short- and mid-term risk of concomitant cardiac surgery at the time of TAVR explant is l …
BACKGROUND: Recent reports have demonstrated worse than expected outcomes of surgical explantation after transcatheter aortic valve replacem …
Predicting 5-Year Clinical Outcomes After Transcatheter or Surgical Aortic Valve Replacement (a Risk Score from the SURTAVI Trial).
van Bergeijk KH, Wykrzykowska JJ, van Mieghem NM, Windecker S, Sondergaard L, Gada H, Li S, Hanson T, Deeb GM, Voors AA, Reardon MJ. van Bergeijk KH, et al. Among authors: reardon mj. Am J Cardiol. 2023 Aug 1;200:78-86. doi: 10.1016/j.amjcard.2023.05.036. Epub 2023 Jun 10. Am J Cardiol. 2023. PMID: 37307783 Free article. Clinical Trial.
Risk prediction scores for long-term outcomes after transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (SAVR) are lacking. ...
Risk prediction scores for long-term outcomes after transcatheter aortic valve implantation (TAVI) or surgical aortic valve replaceme …
Transcatheter Mitral Valve Replacement with Dedicated Devices.
Aoun J, Reardon MJ, Goel SS. Aoun J, et al. Among authors: reardon mj. Methodist Debakey Cardiovasc J. 2023 May 16;19(3):50-56. doi: 10.14797/mdcvj.1231. eCollection 2023. Methodist Debakey Cardiovasc J. 2023. PMID: 37213879 Free PMC article.
Early feasibility studies have demonstrated good technical success and short-term outcomes, but larger samples and longer-term outcomes still need to be assessed. ...
Early feasibility studies have demonstrated good technical success and short-term outcomes, but larger samples and longer-term …
Transcatheter Aortic Valve Implantation: Long-Term Outcomes and Durability.
Desai PV, Goel SS, Kleiman NS, Reardon MJ. Desai PV, et al. Among authors: reardon mj. Methodist Debakey Cardiovasc J. 2023 May 16;19(3):15-25. doi: 10.14797/mdcvj.1201. eCollection 2023. Methodist Debakey Cardiovasc J. 2023. PMID: 37213878 Free PMC article. Review.
Long-term outcomes and durability of transcatheter heart valves have become substantially important for this younger population due to their longer life expectancy. The lack of standardized definitions of bioprosthetic valve dysfunction and disagreement about how to accoun …
Long-term outcomes and durability of transcatheter heart valves have become substantially important for this younger population due t …
Explant vs Redo-TAVR After Transcatheter Valve Failure: Mid-Term Outcomes From the EXPLANTORREDO-TAVR International Registry.
Tang GHL, Zaid S, Kleiman NS, Goel SS, Fukuhara S, Marin-Cuartas M, Kiefer P, Abdel-Wahab M, De Backer O, Søndergaard L, Saha S, Hagl C, Wyler von Ballmoos M, Bhadra O, Conradi L, Grubb KJ, Shih E, DiMaio JM, Szerlip M, Vitanova K, Ruge H, Unbehaun A, Kempfert J, Pirelli L, Kliger CA, Van Mieghem N, Hokken TW, Adrichem R, Modine T, Corona S, Wang L, Petrossian G, Robinson N, Meier D, Webb JG, Cheung A, Ramlawi B, Herrmann HC, Desai ND, Andreas M, Mach M, Waksman R, Schults CC, Ahmad H, Goldberg JB, Geirsson A, Forrest JK, Denti P, Belluschi I, Ben-Ali W, Asgar AW, Taramasso M, Rovin JD, Di Eusanio M, Colli A, Kaneko T, Nazif TN, Leon MB, Bapat VN, Mack MJ, Reardon MJ, Sathananthan J. Tang GHL, et al. Among authors: reardon mj. JACC Cardiovasc Interv. 2023 Apr 24;16(8):927-941. doi: 10.1016/j.jcin.2023.01.376. JACC Cardiovasc Interv. 2023. PMID: 37100556
75 results